Senior Scientist — Immune-Oncology Translational

Bristol Myers Squibb; Cambridge (MA); On-site; USD 142,000 - 172,000; Full time

Job summary

Bristol Myers Squibb in Cambridge, MA is seeking a Senior Scientist, Translational Development to lead preclinical labs overseeing immune-oncology programs beyond phase 2. This role reports to the Translational Development leadership and drives bench-to-clinic strategies.

You will collaborate with Translational Medicine and other teams to generate data on mechanism of action, biomarkers, and resistance, guiding program decisions and development plans.

Qualifications

• PhD with at least 2 years of relevant work experience in immune-oncology or immunology.
• Excellent publication record in high-tier journals and strong research track record.

Responsibilities

• Performs preclinical/laboratory studies involving late-stage BMS assets to support annual goals and objectives for the Translational Medicine research group
• Deliver data in support of translational strategies including biomarkers, patient selection hypotheses, dose and schedule, combination strategies, resistance mechanisms and differentiation
• Interfaces with other research scientists within and outside of Translational Medicine to ensure seamless flow of information
• May contribute to external preclinical collaborations across the clinical asset pipeline
• Accurately maintain written reports and present results in an organized and timely manner
• Communicate effectively, foster teamwork and contribute to project strategy discussions

Skills

Immune-oncology

Publication record

Written communication

Team collaboration

Education

PhD in relevant field

Tools

Akoya

Visium

COSMX

Job description

Bristol Myers Squibb in Cambridge, MA is seeking a Senior Scientist, Translational Development to lead preclinical labs overseeing immune-oncology programs beyond phase 2. This role reports to the Translational Development leadership and drives bench-to-clinic strategies.

You will collaborate with Translational Medicine and other teams to generate data on mechanism of action, biomarkers, and resistance, guiding program decisions and development plans.